Sun Pharmaceutical standalone Q2 net down to Rs 888.6 crore
The company's Board also approved the Scheme of Arrangement for amalgamation of five subsidiaries into Sun Pharmaceutical and reclassification of general reserves to retained earnings, subject to necessary approvals.
Pharma major Sun Pharmaceutical Industries Ltd said it closed Q2FY24 with lower operational revenue, image credit: Reuters